Symbol
| CBX7
| contributors: mct - updated : 17-05-2023
|
HGNC name
| chromobox homolog 7
|
HGNC id
| 1557
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in prostate tumor cells | tumoral
|  
|  
| --over
|  
|
in follicular lymphoma | tumoral
|  
|  
| --low
|  
|
drastically down-regulated in six thyroid carcinoma cell lines | tumoral
|  
|  
| --low
|  
|
loss of CBX7 expression correlates with a highly malignant phenotype in thyroid cancer patients | tumoral
|  
|  
| --over
|  
|
in gastric cancer cell lines and gastric tumors | tumoral
|  
|  
| --low
|  
|
significantly downregulated in pancreatic ductal adenocarcinoma, compared to normal pancreatic tissues | constitutional
|  
|  
|  
| loss of function
|
plays a positive role in dentin and alveolar bone formation | tumoral
|  
|  
| --low
|  
|
loss of CBX7 expression might play a critical role in advanced stages of carcinogenesis by deregulating the expression of specific effector genes | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| CBX7 might serve as a promising biomarker in Lung adenocarcinoma (LUAD) | |
important prognostic factor, whose loss of expression in general indicates a bad prognosis and a progression towards a fully malignant phenotype | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | hemopathy | | |
target for control of follicular lymphoma in the clinic | cancer | lung | | |
CBX7 might serve aspotential molecular target in Lung adenocarcinoma (LUAD) |
| | |
| Cbx7-knockout mice had a higher fat tissue mass than wild-type, suggesting a role of CBX7 in adipogenesis |